Aimei Health Technology Co., Ltd. (AFJK) Financials
Annual revenue, profitability and per-share results for Aimei Health Technology Co., Ltd., as reported in SEC filings.
Net income • FY2025
$1.06M
▼ 58.5%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $1.06M | — | — | — | — | — |
| FY2024 | — | $2.55M | — | — | — | — | — |
| FY2023 | — | — | — | $0.08 | — | — | — |
Figures as reported in Aimei Health Technology Co., Ltd.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a AFJK filing.
Get an email when AFJK files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.